LC
TEVA icon

Loews Corp’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Loews Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,530
Closed -$239K – 214
2014
Q1 		$239K Buy
+4,530
New +$209K ﹤0.01% 164
2013
Q3 		– Sell
-5,755
Closed -$226K – 201
2013
Q2 		$226K Buy
+5,755
New +$224K ﹤0.01% 153

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Loews Corp's TEVA Position: Q2 2014 in Review

Loews Corp sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2014, closing a stake of 4,530 shares — an estimated $239K sold.

Loews Corp first reported a position in TEVA in Q2 2013 and held it in 2 quarters. The position peaked at $239K in Q1 2014. 780 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

  • Loews Corp reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2014 after selling out during the quarter.
  • Loews Corp sold 4,530 Teva Pharmaceutical Industries Limited shares in Q2 2014, an estimated $239K.
  • Loews Corp first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 2 quarters.
  • Loews Corp's Teva Pharmaceutical Industries Limited position peaked at $239K in Q1 2014.
  • 780 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2014.

Based on Loews Corp's 13F filing for Q2 2014, filed 13 Aug 2014.